MagPortal.com   Clustify - document clustering
 Home  |  Newsletter  |  My Articles  |  My Account  |  Help 
Similar Articles
The Motley Fool
February 14, 2006
Rich Duprey
Cutera's Laser Woes Aesthetic laser maker has a cloudy future of lower sales, earnings, and patent lawsuits. Investors, take note. mark for My Articles similar articles
The Motley Fool
April 30, 2007
Rich Duprey
Foolish Forecast: Cutera Zaps Quarter Investors, don't expect the aesthetic laser maker to burn up the growth charts when it reports first-quarter results. mark for My Articles similar articles
The Motley Fool
April 3, 2007
Rich Duprey
Palomar Medical Burns Another Rival The aesthetic laser maker zaps a privately held firm for patent infringement. But one company not buckling under to Palomar's aggressive tactics is Candela. Investors, take note. mark for My Articles similar articles
The Motley Fool
May 8, 2007
Rich Duprey
Cutera's Ugly Quarter The aesthetic laser maker's weak domestic sales dim the outlook for the rest of the year. Investors, take note. mark for My Articles similar articles
The Motley Fool
April 9, 2007
Rich Duprey
Cutera's Meltdown The maker of aesthetic lasers lowers guidance, and Mr. Market's reaction isn't surprising. mark for My Articles similar articles
The Motley Fool
December 14, 2005
Stephen D. Simpson
An Ugly Battle in Aesthetics Palomar Medical Tech scores an initial win over Cutera in an intellectual property battle, but the war isn't over yet. Investors, take note. mark for My Articles similar articles
The Motley Fool
August 22, 2006
Rich Duprey
Candela Goes Dark Atop recent legal woes, the laser maker reports gloomy quarterly earnings. Investors, take note. mark for My Articles similar articles
The Motley Fool
August 18, 2006
Rich Duprey
Candela Singed by Patent Lawsuit The cosmetic laser maker, hit by rival's claim of infringement, fires back with a counterclaim. Investors, with Candela releasing its earnings report next week, this is sure to be a white hot topic on the conference call. Investors, take note. mark for My Articles similar articles
The Motley Fool
April 10, 2007
Rich Duprey
The Beauty of Lasers With aesthetic laser treatments booming, which company looks the best? Candela... Cutera... Palomar Medical Technologies... Cynosure... Syneron... mark for My Articles similar articles
The Motley Fool
April 7, 2008
Rich Duprey
No Class Act at Candela A class action lawsuit could burn the aesthetic-laser maker. mark for My Articles similar articles
The Motley Fool
February 11, 2005
Stephen D. Simpson
Laser Beamer Lookin' Good Palomar continues to build a profitable business in the highly competitive cosmetic laser market. mark for My Articles similar articles
The Motley Fool
April 17, 2007
Rich Duprey
Foolish Forecast: A Bet Candela Can't Afford to Lose The aesthetic laser maker is set to report third-quarter 2007 financial results. Investors, here is what you can expect to see. mark for My Articles similar articles
The Motley Fool
January 17, 2007
Rich Duprey
Foolish Forecast: Dim Hope for Candela The aesthetic-laser maker will report second-quarter 2007 financial results shortly. Investors, here what to expect. mark for My Articles similar articles
The Motley Fool
January 10, 2006
Rich Duprey
Biolase Brightens Outlook The aesthetic laser company expects to be cash flow-neutral on flat revenues. Investors cheer. mark for My Articles similar articles
The Motley Fool
April 22, 2008
Rich Duprey
Foolish Forecast: No Sizzle at Candela In advance of earnings, analysts expect sales from aesthetic laser maker Candela to be essentially flat. mark for My Articles similar articles
The Motley Fool
February 13, 2007
Rich Duprey
Palomar's Parallax View A plethora of one-time revenues skewed the aesthetic laser maker's results. Investors, take note. mark for My Articles similar articles
The Motley Fool
October 26, 2006
Rich Duprey
Candela's October Surprise The aesthetic laser maker trounces analyst projections, though all may not be what it seems. Investors, take note. mark for My Articles similar articles
The Motley Fool
May 5, 2005
Rich Duprey
Candela Brightens on Sales Growth The laser manufacturer reports record revenues and growing profits. Though not a sell, this stock isn't as hot as expected. mark for My Articles similar articles
The Motley Fool
August 26, 2005
Rich Duprey
Candela Burns Holes in Logic The cosmetic laser manufacturer claims success via questionable mental gymnastics. Perhaps it ought to trim the fat off its verbiage and spare investors any more unneeded workouts. mark for My Articles similar articles
The Motley Fool
January 24, 2007
Rich Duprey
Candela's Number Is Up The aesthetic laser maker reports dismal results that fall short of its own fuzzy math expectations. mark for My Articles similar articles
Bio-IT World
June 17, 2004
Cathryn Campbell
Patent Plaintiff Perils Suing for patent infringement may seem rewarding, but you could lose even more. mark for My Articles similar articles
The Motley Fool
April 24, 2008
Rich Duprey
Candela Fizzles Aesthetic laser maker Candela reports slightly higher revenue but wider-than-anticipated losses. mark for My Articles similar articles
The Motley Fool
July 30, 2007
Brian Orelli
Palomar Plummets In the second quarter, cosmetic-laser maker Palomar Medical Technology had a stellar performance in the former, but investors couldn't look past the lack of royalty payments. mark for My Articles similar articles
The Motley Fool
January 31, 2008
Rich Duprey
Candela Investors Burned Again The aesthetic-laser maker continues its string of disappointing quarters. mark for My Articles similar articles
The Motley Fool
April 25, 2007
Rich Duprey
Candela's Amazing Shrinking Quarter The aesthetic laser maker reports its second consecutive quarter of declining sales. Investors, take note. mark for My Articles similar articles
InternetNews
November 30, 2010
Microsoft's i4i Appeal Headed for Supreme Court Microsoft will get a chance to make its case to the U.S. Supreme Court, appealing the earlier patent infringement decision it lost to i4i. mark for My Articles similar articles
Information Today
May 2006
George H. Pike
Feature: BlackBerry: Lawsuit and Patent Reform Whether through the courts or before Congress, the BlackBerry experience suggests that some modification of patent law is not only likely, it's necessary. mark for My Articles similar articles
The Motley Fool
August 28, 2007
Rich Duprey
Candela's Chance to Fan the Flames The maker of lasers used in aesthetic procedures receives FDA approval for an innovative pain reduction technology. Investors, it needs something. Sales have been giving off a pretty weak signal lately, and management admits it has been losing market share. mark for My Articles similar articles
The Motley Fool
November 11, 2008
Brian Orelli
Two Years of Red Aesthetic laser makers have been rocked over the last few years. mark for My Articles similar articles
Information Today
September 15, 2011
George H. Pike
Congress Enacts Patent Reform Legislation In what is being described as the most substantial overhaul of U.S. patent law in nearly 60 years, Congress passed the Leahy-Smith America Invents Act, patent reform legislation that has been years in the making. mark for My Articles similar articles
The Motley Fool
November 2, 2005
Rich Duprey
Can Candela Regain Focus? Aesthetic laser maker reports strong gains, but can it do so consistently? It has new products, new distributors, and new markets to expand into, along with a shareholder-friendly stock buyback program. mark for My Articles similar articles
The Motley Fool
May 3, 2006
Rich Duprey
Candela's Cool Beam The aesthetic laser manufacturer reports steady revenues and profits. Candela's not a cheap stock at these prices, even with the sell-off. mark for My Articles similar articles
The Motley Fool
August 15, 2008
Brian Orelli
Syneron Medical's Bipolar Growth While U.S. sales sink, international sales are keeping the medical laser making company afloat. mark for My Articles similar articles
The Motley Fool
September 27, 2007
Brian D. Pacampara
5 More Turnaround Stocks These companies may be poised for turnarounds: Alberto-Culver, ACI Worldwide, Palomar Medical Technologies, Carter's, and Aspreva Pharmaceuticals. Investors should consider, but with caution. mark for My Articles similar articles
The Motley Fool
March 15, 2007
Rich Duprey
Candela Eases the Pain The aesthetic laser maker acquires an innovative technology that minimizes pain. Investors, it's essentially an investment in the future, but one that still entails some risk. mark for My Articles similar articles
Information Today
September 6, 2012
Paula J. Hane
Apple-Samsung Case Highlights America's Troubled Patent System The jury finding in this case has triggered an onslaught of commentary and has also brought up many questions about the nature of the U.S. patent system. The comments have ranged from "software patents are evil" to the U.S. has a "broken patent system." mark for My Articles similar articles
IndustryWeek
August 1, 2006
Patents: Eleven Issues To Consider... How patent savvy are you? mark for My Articles similar articles
CIO
September 28, 2011
Grant Gross
Controversial Business-Method Patents Face New Attacks A new law revamps the patent system and gives rivals an eight-year window to challenge IT-related patents in the financial-services industry. mark for My Articles similar articles
National Defense
June 2008
Jerry Stouck
Right and Wrong Ways To Use Others' Patents By statute, the military and other government agencies have the right to use any patented invention to further valid government missions, and this right may be extended to government contractors. mark for My Articles similar articles
The Motley Fool
February 13, 2008
Stephen Albainy-Jenei
One Privileged Position Biomedical Patent Management sued the California Department of Health Services, claiming patent infringement, but the State of California can claim immunity from patent suits. mark for My Articles similar articles
InternetNews
March 3, 2006
Roy Mark
Trolling for Patents Patent infringement claims are easy to make and difficult to disprove. mark for My Articles similar articles
The Motley Fool
September 10, 2007
Rich Duprey
A Strategic Alternative for Candela In an SEC filing, hedge fund Third Point LLC reports its discussions of "strategic alternatives" at laser maker Candela. Some say a sale was discussed. Investors should take notice. mark for My Articles similar articles
InternetNews
October 12, 2009
Microsoft Seeks Patent on Timed S/W Licenses Patent could change the way users 'buy' software or the way Microsoft lets you use it. mark for My Articles similar articles
InternetNews
April 26, 2005
Roy Mark
Tech Wants Patent 'Trolls' Tamed Intel's top patent attorney urged a Senate panel Monday to crack down on "trolls" who manipulate the patent system for large profits. mark for My Articles similar articles
Inc.
June 2006
Athena Schindelheim
Great Moments In Patent History With the blockbuster BlackBerry settlement and a case involving eBay before the Supreme Court, the dowdy world of patent law is suddenly hot. mark for My Articles similar articles
InternetNews
March 28, 2011
Kodak CEO Hopes for $1 Billion in Patent Suit Eastman Kodak's head told Bloomberg he thinks a patent victory in court could bring in $1 billion. Kodak sued Apple and RIM in January 2010 for what it claims is infringement of a patent it holds in the area of previewing images in iPhone and Blackberry mobile devices. mark for My Articles similar articles
InternetNews
April 9, 2009
Stuart J. Johnston
Microsoft's Patent Tab: $388M Ought to Do It Jury finds that Microsoft infringed a California company's activation software patent to the tune of nearly $400 million. mark for My Articles similar articles
The Motley Fool
December 7, 2006
Matt Koppenheffer
The Best Small Cap for 2007: Syneron This Israel-based aesthetic laser company has financials that need no cosmetic touch-ups. Investors, take note. mark for My Articles similar articles
InternetNews
October 6, 2009
Eolas Sues Almost Everybody Over Browser Apps After Eolas' patent was extended, the tiny firm is taking it to the courts. mark for My Articles similar articles
Pharmaceutical Executive
March 1, 2011
A Rule of Thumb Gets Shot Down The Federal Circuit court continues its trend in tightening the standards for establishing patent damages by leapfrogging a stalled legislative process. mark for My Articles similar articles